Study Support Grants are available to PeDRA Members only. Please login or join PeDRA to access this content.
Evidence-based consensus recommendations published by experts in the management of disease are a critical fiber of the healthcare fabric. Healthcare providers rely on guidelines and expert recommendations to inform treatment decisions and insurance providers rely on these to design formularies. Researchers compare new therapeutic or procedural interventions to standard-of-care practice guidelines in randomized controlled trials. However, many diseases still lack up-to-date recommendations or expert consensus recommendations, resulting in wide variability in practice patterns, and leaving many patients without access to treatment they need. Evidence-based guidelines and expert consensus best practice recommendations are lacking for many pediatric skin diseases.
To help address this need, PeDRA is calling for submissions to its 2022 Consensus Grant program, which will provide up to $25,000 of support for the creation of consensus recommendations, best practice recommendations, or consensus treatment plans for the treatment of diseases in the field of pediatric dermatology in the United States and/or Canada. Interested teams are invited to submit proposals to create consensus-based recommendations or best practice recommendations for a disease of their choice, using a rigorous methodology of their choice. However, priority will be given to proposals that address diseases for which contemporary guidelines do not exist, and which use established consensus methodology.
- Up to $25,000 for one year to support the creation of consensus recommendations or best practice recommendations for the management of diseases in the field of pediatric dermatology
- Applications due Thursday, December 1, 2022
Past Consensus Grant Recipients:
Nanette Silverberg, MD
2021 Consensus Grant
Icahn School of Medicine at Mount Sinai
Pediatric and Adolescent Vitiligo Guidelines
Alex Zvulunov, MD & Elena Pope, MD, MsC
2019 Consensus Guidelines Award
Consensus-based recommendations for management of pediatric Mycosis Fungoides: the ARMFUL (AppRoach Mycosis FUngoides in chiLdren) study
Alopecia areata (AA) is a common autoimmune skin disease that causes hair loss on the scalp, face, and sometimes on other areas of the body, and affects as many as 147 million people worldwide. Nearly half of patients experience their first episode of alopecia areata before age 20. A diagnosis early in life is linked to higher disease severity and poorer prognosis, making pediatric alopecia areata an important target for research and therapeutic intervention. Despite recent advances, there are no FDA-approved treatments for pediatric alopecia areata. The burdens on these patients, and their families, can be significant and many important research questions remain unanswered.
To address this need, the National Alopecia Areata Foundation (NAAF) and PeDRA are collaborating to support research investigations focused on pediatric alopecia areata with the Pediatric Alopecia Areata Challenge Grant. Through this grant, NAAF and PeDRA intend to accelerate research that improves the lives of pediatric alopecia areata patients and their families.
This Challenge Grant is intended to stimulate scientists to establish or sustain research programs focused on pediatric alopecia areata. Investigators with any innovative research idea are encouraged to apply for the challenge grant, with priority consideration given to proposals that address one or more of the following areas of interest:
• Investigations of targets or pathways that will advance understanding of the pathophysiology of pediatric AA
• Investigations of epidemiology or the natural history of pediatric AA
• Elucidation of the burden of pediatric alopecia areata on patients and families including the psychosocial impact
• Advances in treatment or tools for treatment decision-making by patients and families
Priority consideration will be given to projects led by early-to-mid career principal investigators collaborating with senior mentors and projects that address high-priority research questions. Additional priority will be given to applications that support NAAF and PeDRA’s commitments to advancing equity, diversity, and inclusion across all facets of their organizations and the research they support.
- Up to $50,000 to support one year of research
- One award anticipated for this funding cycle
- Earliest project start date: Wednesday, February 15, 2023
- Application deadline: Tuesday, November 15, 2022
Childhood skin diseases are associated with severe burden on patients, families, and health care providers. Despite this burden, effective treatments remain sparse and the pace of research slow. To help overcome these challenges, the Pediatric Dermatology Research Alliance (PeDRA) is committed to supporting an annual competitive research grants program.
As part of this program, this year PeDRA is offering PeDRA Research Grants to support early-stage research projects where preliminary data may be lacking, and to establish infrastructure and foster collaborations that support larger-scale studies in future. Applications may be submitted by either a single investigator or multiple investigators at multiple institutions to receive:
$40,000 to be used over two years to support larger scale projects.
$20,000 to be used over either one or two years to support more modestly sized projects requiring less financial support.
Up to $20,000 to be used over one year to support smaller scale pilot projects.
PeDRA Research Grants are driven by the mission to create, inspire, and sustain research to prevent, treat, and cure childhood skin disease. They are intended to provide financial support for early-stage studies that are unlikely to be funded elsewhere, and to provide a mentorship opportunity for both grant preparation and project execution. Ultimately, PeDRA Research Grants are expected to generate data, establish research infrastructure, and foster collaborations that form the basis for larger scale studies with a high impact on patient lives.
- May be submitted by individuals or teams.
- Applications due Thursday, September 29, 2022.
- Optional opportunity to submit a preliminary application by August 15, 2022 to be eligible to receive preliminary reviewer comments and discuss their applications with a representative from the PeDRA Grants Committee.
Last Year’s Research Grant Recipients:
Anna Garza-Mayers, MD, PhD
University of Massachusetts Chan Medical School
Assessment of hearing and vision in pediatric vitiligo patients
JiaDe Yu, MD
Massachusetts General Hospital
Evaluation of the Efficacy of Popular Over the Counter Ointments in Atopic Dermatitis: A Double Blinded Randomized Controlled Trial
Run in partnership with the Society for Pediatric Dermatology.
Childhood skin diseases are associated with severe burden on patients, families, and health care providers. Despite this burden, effective treatments are sparse, the pace of research is slow, and board-certified pediatric dermatologists remain few-in-number. To support the development of the next generation of clinician scientists in the field, the Pediatric Dermatology Research Alliance (PeDRA), together with the Society for Pediatric Dermatology (SPD), is offering the 2022 William Weston Career Development Award (CDA) to support one early career investigator in the conduct of an innovative research study under the direction of a senior mentor. Applications may be submitted by a pediatric dermatologist no more than seven years out of training for $40,000 per year to support salary and research activities for up to two years.
The Weston CDA is driven by PeDRA’s and SPD’s commitment to support both research and researchers in the field of pediatric dermatology. It is intended to provide protected research time, resources, and expert mentorship for an early career clinician scientist. Ultimately, the Weston CDA is expected to help position the recipient for a long-term career in the field with the potential to obtain funding from the Dermatology Foundation, NIH, or other agencies in future.
- $40,000 per year for up to two years of support for early-career pediatric dermatologists
- To support the conduct of a research project under the mentorship of a senior investigator
- Applications due Thursday, September 29, 2022
Previous Weston CDA Recipients:
Rebecca Levy, MD, FRCPC
2021 Weston Career Development Award
Hospital for Sick Children, Toronto
Characterizing the Cutaneous Late Effects in Pediatric Hematopoietic Stem Cell Transplantation Recipients
Lucinda Kohn, MD, MHS
2019 Weston Career Development Award
University of Colorado Denver
Expanding Access to Severe Acne Care for Navajo Adolescents Through Education
Emily Gurnee, MD
2020 Weston Career Development Award
University of Colorado Denver
Investigating the role of Staphylococci in Pediatric Skin Disease
Jennifer Schoch, MD
2018 Weston Career Development Award
University of Florida
Unraveling Determinants of the Early Cutaneous Microbiome
Childhood skin diseases are associated with severe burden on patients, families, and health care providers. Despite this burden, effective treatments are sparse, the pace of research is slow, and board-certified pediatric dermatologists remain few-in-number. Furthermore, mid-career clinician scientists in the field often encounter challenges after receiving early career start up funds from their institution, traditional career development awards, or small pilot grants, which may contribute to stress, increased prioritization of clinic work over research, and high rates of burnout.
To better support the full career trajectory of clinician scientists in the field, the Pediatric Dermatology Research Alliance (PeDRA) is offering the 2022 Career Bridge Research Grant to support one mid-career investigator in the conduct of an innovative research study in the field of pediatric dermatology. Applications may be submitted by a pediatric dermatologist between seven and fifteen years out of training for $80,000 to support salary and research activities for up to two years.
The Career Bridge Research Grant is driven by PeDRA’s commitment to support both research and researchers in the field of pediatric dermatology. It is intended to provide protected research time and resources for a mid-career clinician scientist conducting high-impact research in the field. Ultimately, the Career Bridge Research Grant is expected to propagate the career of the recipient through the challenging mid-career phase and give them the potential to obtain larger-scale, longer-term funding from the NIH or other agencies.
Priority consideration will be given to mid-career investigators collaborating with senior mentors, projects that address high-priority patient-centered research questions, and projects that align with the focus of any of PeDRA’s Focused Study Groups. Additional priority will be given to applications that support PeDRA’s commitment to advancing equity, diversity, and inclusion across all facets of its organization and pediatric dermatology research. Diversity and inclusion strengthen the PeDRA research network and are critical to the pursuit of its mission.
- $80,000 to support salary and research activities for up to two years for mid-career pediatric dermatologists
- Priority consideration to mid-career investigators collaborating with senior mentors, projects that address high-priority patient-centered research questions, and projects that align with the focus of any of PeDRA’s Focused Study Groups
- Applications due Thursday, September 29, 2022
Previous Career Bridge Recipients:
This webinar is for PeDRA Active members and/or Trainees only. Members - please click here to enter your log-in information. If you have any questions or concerns, please contact us at email@example.com.